Related Experiment Videos

[Hydroxychinoline- and zinc-treated acrodermatitis enteropathica and electroretinographic findings (author's transl)]

Klinische Padiatrie
|March 1, 1978
PubMed

Insights

Severe acrodermatitis enteropathica in a boy was treated with hydroxychines and later with oral zinc. Daily zinc supplementation improved skin symptoms and vision, despite optic atrophy.

Area of Science:

  • Dermatology
  • Ophthalmology
  • Pediatrics

Background:

  • Acrodermatitis enteropathica is a rare genetic disorder of zinc absorption.
  • Long-term management of this condition can be challenging, particularly regarding potential complications.

Observation:

  • A 13-year-old boy with a history of severe acrodermatitis enteropathica since infancy presented with visual deterioration due to optic atrophy at age 5.
  • Previous treatments included hydroxychines with dose adjustments and halogen substitutions, but symptoms persisted.

Findings:

  • Daily oral zinc supplementation and regular serum zinc monitoring resolved all cutaneous and mucous membrane symptoms.
  • Ophthalmoscopic status remained unchanged, but visual acuity slightly improved, peripheral visual field expanded, and electroretinographic potentials normalized.

Implications:

  • This case highlights the critical role of consistent zinc management in acrodermatitis enteropathica.
  • Effective zinc therapy can potentially ameliorate visual disturbances associated with the condition, even in the presence of optic atrophy.

Related Concept Videos